Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.
Also called NCT01252420
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT01252420
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, New Zealand
- Registry status
- Unknown status
Technical summary
Registry record NCT01252420. Allocation not applicable; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2013-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
- Acronym
- TWISTER
- Condition
- Venous Thrombosis
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Enoxaparin
- Lead sponsor
- Monash Medical Centre
- Collaborator
- Southern Health, Victoria
- Collaborator
- Eastern Health, Victoria
- Collaborator
- Royal Adelaide Hospital
- Collaborator
- Prince of Wales Hospital, Sydney
- Collaborator
- Christchurch Hospital
- Collaborator
- Auckland City Hospital
- Collaborator
- North Shore Hospital, New Zealand
- Collaborator
- Middlemore Hospital, New Zealand
Record details
- Record id
cardio:ct-nct01252420- Content hash
8c05b7f94e3977e1bf9b81ed0b9ac957d1a27ba147e6ec3044e7aa2760bb65d2